US regulator approves Botox to treat specific form of urinary incontinence
Posted Sep 09 2011 1:37am
Issue Codes Incontinence Products for Women
The US Food and Drug Administration (FDA) has approved Botox as a treatment for a particular type of urinary incontinence that affects some people with neurologic conditions, such as spinal cord injury and multiple sclerosis.
These patients are prone to overactive bladder, as they may experience uninhibited bladder contractions.